🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
GKO
$GKOS
🔒 US EquitiesGlaukos Corporation
AVG HISTORICAL GAP
+2.83%
MAX GAP RECORD
+23.32%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $GKOS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$GKOS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (AFTER CLOSE (16:00)) |
+16.30%
|
| Jul 29, 2026 Earnings Release 2026-07-29 (AFTER CLOSE) |
+11.48%
|
| Apr 29, 2026 Earnings Release 2026-04-29 (AFTER CLOSE) |
+20.98%
|
| Feb 17, 2026 Earnings Release 2026-02-17 (AFTER CLOSE) |
-2.90%
|
| Oct 29, 2025 Earnings Release 2025-10-29 (AFTER CLOSE) |
+23.32%
|
| Jul 30, 2025 Earnings Release 2025-07-30 (AFTER CLOSE) |
-0.58%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE) |
-10.43%
|
| Feb 20, 2025 Earnings Release 2025-02-20 (AFTER CLOSE) |
-10.17%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
8.4%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (2)
📖 Intelligence Summary
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗